High Field
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $16M
Investors
- 6
About High Field
Established in 2013 and based in Hangzhou, China, High Field is a biomedical company that focuses on the development of innovative lipid nano drugs. Dr. Yuhong Xu, the company’s founder and CSO, served as a preparation researcher at Chiron Corp and the director of translational medicine at GSK (Shanghai) R&D Center. The company engages in the development of innovative lipid nano drugs. It has three major lipid technology platforms: small molecule liposomes, antibody-conjugated liposomes and nucleic acid lipid nanoparticles. Its main product is mRNA vaccine. The company's products are used in the treatment of tumors, autoimmune and metabolic diseases.
Who invested in High Field
6 investors across 3 rounds
See all investors in High Field
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about High Field
Who invested in High Field?
High Field has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has High Field raised?
High Field has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did High Field last raise money?
High Field's most recent round on record is a Series B, in Dec 2021.
What does High Field do?
Established in 2013 and based in Hangzhou, China, High Field is a biomedical company that focuses on the development of innovative lipid nano drugs.
Where is High Field headquartered?
High Field is headquartered in Hangzhou, China.
Which VCs invest in companies like High Field?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at High Field's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like High Field? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.